Dietary Supplements

A dietary supplement is defined as a product taken by mouth containing a dietary ingredient intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs or other botanicals, and amino acids.

Select an Issue

Dietary Supplement Resource Library

Explore our list of resources to learn more about the dietary supplement category and how it is regulated by the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC).

Explore
Woman Shopping for Dietary supplements
Dietary Supplements Access Act

The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.

three different kinds of dietary supplement capsules
Explaining the Regulatory Framework for Dietary Supplements

It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.

Sep 28, 2021

Browse Dietary Supplements Content

DS Digest Teaser

Dietary Supplements Digest

Dietary Supplement State and Local Issues- Nov. 4, 2022

Nov 4, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, October 24, 2022

Oct 28, 2022

Test Tubes

Press Releases and Statements

Landmark Paper Published in Regulatory Journal Proposes Safety Assessment Parameters for Probiotics

Jay Sirois, PhD, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper, Considerations for determining safety of probiotics: A USP perspective

Oct 27, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, October 10, 2022

Oct 10, 2022

FDA headquarters sign in Washington DC

Submission

Comments to FDA: Remote Regulatory Assessments Draft Guidance

Sep 30, 2022

U.S. Capitol East Facade in the morning

Press Releases and Statements

CHPA Statement Regarding Congressional Passage of Continuing Resolution to Reauthorize FDA User Fee Programs

(WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription drugs, generic drugs, biosimilars, and medical devices over the next five years.

Sep 30, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Newsletters

Federal Register (FR) Notices, September 12, 2022

Sep 15, 2022

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Statement on Recent COSMOS-Mind Clinical Trial Results

CHPA Senior Vice President of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent COSMOS-Mind study, revealing statistically significant improvement on global cognition in participants who took a multivitamin over the course of the long-term clinical trial:

Sep 14, 2022

three different kinds of dietary supplement capsules

Submission

Comments to NIH: ODS Strategic Plan 2022-2026

CHPA appreciates the opportunity to provide comments on NIH ODS strategic plan 2022-2026.

Sep 1, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Newsletters

Federal Register (FR) Notices, August 29, 2022

Summary Excerpts from Select Federal Register Notices for CHPA Weekly Voice Week of August 29, 2022

Sep 1, 2022

Filter Results

On Capitol Hill

CHPA is a proud supporter of the Congressional Dietary Supplement Caucus (DSC), a bipartisan forum for the exchange of ideas and information regarding dietary supplements in the U.S. House of Representatives and the Senate.

Learn More